Tandem Diabetes Care, Inc.
TNDM
$21.01
$0.281.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.97% | -70.05% | -205.64% | 102.52% | 29.46% |
| Total Depreciation and Amortization | 6.70% | 6.30% | 6.63% | 5.31% | 4.67% |
| Total Amortization of Deferred Charges | -11.55% | 6.90% | -22.31% | 1.83% | -28.49% |
| Total Other Non-Cash Items | -9.42% | -1.97% | 350.88% | 7.36% | 35.31% |
| Change in Net Operating Assets | -118.88% | 207.94% | -218.56% | -180.43% | 153.05% |
| Cash from Operations | -69.14% | -80.02% | -128.59% | 248.52% | 48,589.09% |
| Capital Expenditure | 21.89% | 4.02% | 33.48% | 40.97% | 2.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 268.03% | 2,098.77% | 2,128.55% | 170.96% | 66.01% |
| Cash from Investing | 203.22% | 1,742.09% | 281.69% | 130.21% | 59.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -12.04% | -- |
| Repurchase of Common Stock | 65.26% | -- | 85.12% | -- | -145.60% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 65.26% | -1,222.88% | -134.51% | -12.04% | -136.47% |
| Foreign Exchange rate Adjustments | 159.20% | 202.24% | -344.44% | 392.27% | -34.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,974.14% | 193.41% | -14,208.11% | 197.36% | 102.62% |